This bill expands the scope of transparency reports submitted by manufacturers of covered drugs, devices, and medical supplies under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
Actions
Jun 6, 2018
Read twice and referred to the Committee on Finance.